US 11,395,817 J1 (289th)
	Methods and compositions for treatment of epileptic disorders
Matthew During
Assigned to OVID THERAPEUTICS INC.
Trial No. PGR2023-00020, Mar. 15, 2023
Post-Grant Review Certificate for Patent 11,395,817, issued Jul. 26, 2022, Appl. No. 17/024,127, Sep. 17, 2020
Post-Grant Review Certificate issued Feb. 27, 2025